Initial clinical tests show that biosensors could pave the way for a personalized antibiotherapy in the future
Personalized drug therapy, adjusting the dose, dosage intervals, and the duration of treatment to fit individual patients’ needs, are getting more and more important. Frequently, medications are dosed in such a way that each patient receives the same standardized amount of a certain drug.
Thereby, clinical conditions of the patient, such as state of health, metabolism, or other physical factors, are often not sufficiently considered. A researcher team at the University of Freiburg has developed a bioanalytical method which can measure the class of β-lactam antibiotics in human blood on-site – in the operating room, intensive ward or doctor's office, as well as on a house call.
“This way, we can easily determine just how quickly the human body metabolizes a drug,” said the microsystems engineer Dr. Can Dincer, who is the head of the research team. The researchers recently published their results in the journal “Scientific Reports”.
This new method makes it possible to individually adjust the necessary dose of a medication for each patient. “We’ve proven the applicability of our system for a personalized antibiotherapy by on-site monitoring the clearance of drugs in two patients, who were treated with ß-lactam antibiotics, undergoing surgery” Dincer said. “Based on these results, our next step will be to perform a quantitative cohort study that will determine the usefulness of personalized antibiotherapy.”, he added.
Already at the end of 2016, the research team presented its biosensor technology that allows the rapid and simultaneous monitoring of different antibiotics in human blood (www.pr.uni-freiburg.de/pm/2016/pm.2016-11-14.159). In their recently published study, the scientists further developed their system by implementing another natural sensor protein that can quantify β-lactam antibiotics. In human medicine, β-lactam antibiotics are often used to prevent and treat infectious diseases.
Nine researchers from the University of Freiburg were involved in this interdisciplinary study: Richard Bruch, André Kling, Dr. Can Dincer and Prof. Dr. Gerald Urban from the Laboratory for Sensors of the Department of Microsystems Engineering (IMTEK); Balder Rebmann, Dr. Claire Chatelle and Prof. Dr. Wilfried Weber from the Synthetic Biology Lab of the excellence cluster BIOSS Centre for Biological Signalling Studies and the Faculty of Biology; as well as Dr. Steffen Wirth and Prof. Dr. Stefan Schumann from the Department of Anesthesiology and Critical Care of the University of Freiburg Medical Center.
Richard, Bruch, Claire Chatelle, André Kling, Balder Rebmann, Steffen Wirth, Stefan Schumann, Wilfried Weber, Can Dincer, and Gerald Urban, Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy, 2017, Sci. Rep., 7, 3127, http://dx.doi.org/10.1038/s41598-017-03338-z.
Dr. Can Dincer
Department of Microsystems Engineering – IMTEK
University of Freiburg
Phone: +49 (0)761 / 203 - 7264
Rudolf-Werner Dreier | Albert-Ludwigs-Universität Freiburg im Breisgau
New way to look at cell membranes could change the way we study disease
19.11.2018 | University of Oxford
Controlling organ growth with light
19.11.2018 | European Molecular Biology Laboratory
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
19.11.2018 | Event News
09.11.2018 | Event News
06.11.2018 | Event News
19.11.2018 | Materials Sciences
19.11.2018 | Information Technology
19.11.2018 | Life Sciences